```html

Zebra Finch Bird‑Fancier’s Lung

Overview

Bird‑fancier’s lung (BFL) is a type of hypersensitivity pneumonitis (HP) that results from inhaling proteins, spores, and other organic particles from bird droppings, feathers, or nest material. The term “Zebra finch bird‑fancier’s lung” simply specifies that the offending birds are Zebra finches (Taeniopygia guttata), a popular pet among hobbyists because of their bright colors and easy care.

People who keep Zebra finches—or any birds—in close quarters (e.g., in cages, aviaries, or breeding rooms) are at risk of developing an immune‑mediated inflammatory reaction in the lungs. The condition can range from an acute, flu‑like illness to chronic, progressive lung fibrosis.

Who it affects

• Adults aged 20‑60 years, with a slight female predominance (likely because women are more often involved in small‑scale pet‑bird breeding) [1].
• Occupational bird‑keepers (breeders, avian veterinarians, pet‑store workers) and amateur hobbyists.
• Individuals with a prior history of atopy (e.g., allergic rhinitis, asthma) appear to have a modestly increased susceptibility.

Prevalence

• Hypersensitivity pneumonitis overall has a prevalence of 1–12 cases per 100,000 people worldwide. Bird‑fancier’s lung accounts for roughly 25 % of those cases [2].
• Specific data on Zebra finch‑related HP are scarce, but a 2020 review of avian‑related HP identified Zebra finches as the second most common pet bird after canaries, representing ≈12 % of avian HP cases [3].

Symptoms

The clinical picture can be divided into acute, sub‑acute, and chronic phases. Symptoms often overlap, and presentation may vary depending on the intensity and duration of exposure.

Acute (hours‑days after heavy exposure)

• Fever & chills – low‑grade to 38.5 °C.
<
• Dry, non‑productive cough – sudden onset.
• Shortness of breath – worsens with exertion.
• Chest tightness or mild pleuritic pain.
• Fatigue, malaise, headache.

Sub‑acute (weeks‑months of intermittent exposure)

• Persistent dry cough.
• Gradual dyspnea on moderate activity (climbing stairs, brisk walking).
• Low‑grade fever or episodic chills.
• Weight loss (5‑10 % of body weight) due to reduced appetite.
• Occasional wheezing that may be mistaken for asthma.

Chronic (months‑years of ongoing exposure)

• Progressive dyspnea at rest or with minimal exertion.
• Chronic non‑productive cough.
• Fine inspiratory crackles (“Velcro‑like”) heard at lung bases.
• Clubbing of the fingers (in advanced fibrosis).
• Reduced exercise tolerance, fatigue.
• Dry mouth, dysphagia (rare, due to esophageal involvement in severe fibrosis).

Because symptoms mimic common respiratory infections, BFL is often misdiagnosed as “asthma” or “pneumonia.” A detailed exposure history is critical.

Causes and Risk Factors

Pathophysiology

Bird droppings and feather dust contain avian proteins (e.g., serum albumin, ovomucoid) and thermophilic actinomycetes. In susceptible individuals, inhalation triggers a Type III (immune complex) and Type IV (cell‑mediated) hypersensitivity reaction, leading to:

• Alveolar inflammation with lymphocytes and macrophages.
• Granuloma formation.
• In chronic cases, fibroblast activation and collagen deposition → interstitial fibrosis.

Key Risk Factors

• High‑density bird housing – small cages, breeding rooms, or bird‑cages in living spaces.
• Inadequate ventilation – closed rooms or lack of air filtration.
• Duration of exposure – > 4 hours/day for several weeks markedly raises risk.
• Cleaning activities – stirring up dust when scrubbing cages or changing bedding.
• Previous HP or atopy – immune‑system primed to react.
• Smoking – synergistic lung injury; smokers have a 2‑3× higher risk of chronic disease.

Diagnosis

There is no single “gold‑standard” test; diagnosis relies on a combination of clinical, radiologic, and immunologic data.

1. Detailed Exposure History

Clinician asks about bird species, cage size, cleaning frequency, ventilation, and any recent changes in the bird‑keeping environment.

2. Physical Examination

• Fine inspiratory crackles at lung bases.
• Possible tachypnea, tachycardia.
• Clubbing in chronic cases.

3. Laboratory Tests

• Complete blood count – may show mild leukocytosis.
• Serum precipitating antibodies (IgG) against avian antigens (bird‑feather or serum). Positive in 60‑80 % of confirmed cases, but a negative test does not rule it out [4].
• Elevated LDH and Krebs von den Lungen‑6 (KL‑6) can suggest interstitial lung disease.

4. Pulmonary Function Tests (PFTs)

Typical pattern: Restrictive (reduced FVC) with a decreased diffusing capacity for carbon monoxide (DLCO). In early disease, DLCO may fall before spirometry changes are evident.

5. Imaging

• Chest X‑ray – May be normal in acute phase; chronic phase shows reticular opacities, especially in lower zones.
• High‑resolution CT (HRCT) – Modality of choice. Findings include:
  • Ground‑glass opacities (GGOs) with a “mosaic attenuation” pattern.
  • Centri‑lobular nodules.
  • Air‑trapping on expiratory scans.
  • In chronic disease, traction bronchiectasis and honey‑comb cysts.

6. Bronchoscopy with Bronchoalveolar Lavage (BAL)

Shows a lymphocyte‑predominant (> 20 %) cell count, supporting HP. Occasionally, cultures grow Thermoactinomycetes if bacterial colonization contributed.

7. Surgical Lung Biopsy (rare)

Reserved for atypical cases where imaging and serology are inconclusive. Histology reveals interstitial lymphocytic infiltrates, poorly formed granulomas, and, in chronic disease, fibrosis.

Treatment Options

1. Removal of Antigen Exposure

The single most effective intervention is to eliminate or drastically reduce exposure to Zebra finch droppings and feather dust.

• Relocate cages to a well‑ventilated, separate room.
• Use HEPA‑filtered air cleaners.
• Wear N‑95 (or higher) respirators while cleaning.
• Consider re‑homing the birds if severe disease persists.

2. Pharmacologic Therapy

Corticosteroids

• Acute/sub‑acute disease: Oral prednisone 0.5–1 mg/kg/day for 2–4 weeks, then taper over 2–3 months based on clinical response.
• Chronic fibrotic disease: Low‑dose prednisone (5‑10 mg daily) may provide symptom relief, but benefits are modest.

Steroid‑Sparing Immunosuppressants

For patients who cannot taper steroids or relapse despite antigen avoidance.

• Azathioprine 2 mg/kg/day.
• Mycophenolate mofetil 1–1.5 g twice daily.
• Evidence from small observational series suggests improvement in PFTs and HRCT scores [5].

Antifibrotic Agents (for established fibrosis)

Agents approved for idiopathic pulmonary fibrosis (IPF) such as nintedanib or pirfenidone have shown promise in halting progression of HP‑related fibrosis, though data are still emerging.

3. Supportive Care

• **Oxygen therapy** for resting hypoxemia (SpO₂ < 88 %).
• **Pulmonary rehabilitation** – improves exercise tolerance and quality of life.
• Vaccinations: influenza annually, COVID‑19 boosters, pneumococcal (PCV20 or PCV15 + PPSV23).
• Smoking cessation assistance.

4. Procedural Options (Rare)

In advanced fibrotic disease unresponsive to medical therapy, lung transplantation may be considered. Eligibility depends on overall health and ability to avoid antigen re‑exposure post‑transplant.

Living with Zebra Finch Bird‑Fancier’s Lung

Daily Management Tips

• Environmental control – Keep cages in a separate, well‑ventilated room; use airtight containers for bedding; clean cages outdoors when possible.
• Air filtration – Run a HEPA purifier 24 hours a day in the living area and especially where birds are kept.
• Protective equipment – Wear an N‑95 respirator and gloves when handling birds, cleaning cages, or changing substrate.
• Regular monitoring – Schedule pulmonary function tests every 3–6 months; keep a symptom diary noting cough, breathlessness, or fever.
• Medication adherence – Take steroids or immunosuppressants exactly as prescribed; never stop abruptly.
• Stay active – Light aerobic exercise (walking, stationary bike) improves lung capacity; avoid high‑intensity workouts that provoke dyspnea.
• Nutrition – A balanced diet rich in antioxidants (fruits, vegetables) supports immune health; maintain a healthy weight to reduce respiratory burden.
• Psychosocial support – Connect with patient groups (e.g., American Lung Association HP forums) to share coping strategies.

When to Contact Your Healthcare Provider

• New or worsening cough or shortness of breath.
• Fever or chills after cleaning cages.
• Decrease in exercise tolerance or unexplained weight loss.
• Side‑effects from medications (e.g., new rash, abdominal pain, abnormal labs).

Prevention

1. Education – Learn about HP before acquiring birds; understand that even small pet birds can trigger disease.
2. Ventilation – Install exhaust fans or open windows to maintain at least 6 air changes per hour in the bird‑keeping area.
3. Dust reduction – Use dust‑free hardwood or paper bedding; avoid pine shavings that release volatile compounds.
4. Routine cleaning protocols – Wet‑wipe cages, avoid dry sweeping; clean outside the home when possible.
5. Protective gear – N‑95 respirator, gloves, and eye protection for anyone entering the bird‑room.
6. Health screening – Baseline pulmonary function testing for new bird‑keepers, especially those with a history of asthma or allergy.
7. Limit bird density – No more than 2–3 Zebra finches per 1 m² of cage floor space; avoid overcrowding.

Complications

• Progressive pulmonary fibrosis – Leads to chronic respiratory failure.
• Secondary infections – Steroid use and impaired lung defenses increase risk of bacterial pneumonia.
• Pulmonary hypertension – Resulting from chronic hypoxia and vascular remodeling.
• Cor Pulmonale – Right‑heart strain due to long‑standing high pulmonary pressures.
• Medication‑related toxicity – Osteoporosis, glucose intolerance, or liver dysfunction from prolonged steroids or immunosuppressants.
• Psychological impact – Anxiety or depression related to chronic illness and limitation on beloved pet ownership.

When to Seek Emergency Care

---

Sources: 1. Mayo Clinic. “Hypersensitivity pneumonitis.” 2023.
2. WHO. “Occupational respiratory diseases.” 2022.
3. L. Piché et al., “Avian‑related hypersensitivity pneumonitis: A systematic review,” Chest, 2020.
4. CDC. “Bird‑fancier’s lung – health information.” 2021.
5. J. Selman, “Immunosuppressive therapy for chronic hypersensitivity pneumonitis,” American Journal of Respiratory and Critical Care Medicine, 2021.

```